Search
Amgen Inc
AMGNAdd to Watchlist
409.860USD
+5.010+1.24%
Market hours （ET）Quotes delayed by 15 min
221.20BMarket Cap
28.29P/E TTM
Forecast
Currency: USD Updated: 2026-08-06The current earnings forecast score of Amgen Inc is 6.86, ranking 120 out of 156 in the Pharmaceuticals industry. The average price target is 323.50, with a high of 400.00 and a low of 180.00.
Analyst Rating
Based on
37
analysts
Hold
Current Rating
373.989
Target Price
-4.11%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Amgen Inc
AMGN
37
Biogen Inc
BIIB
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
32
Pfizer Inc
PFE
32
Merck & Co Inc
MRK
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Amgen Inc's expected revenue for the next quarter?
Amgen Inc's expected revenue is 9.94B.
What is Amgen Inc's price target?
Analysts forecast that Amgen Inc's price target is USD 323.50, with the highest forecast at USD 400.00 and the lowest forecast at USD 180.00.
How have Amgen IncAMGN's recent earnings per share performed?
The market expectation was USD 4.40, while Amgen IncAMGN's earnings per share (EPS) for the previous quarter was USD 3.37. EPS for the next quarter is expected at USD 5.78.
What is the analyst rating for Amgen Inc?
Based on the ratings of Amgen Inc's stock from 37 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.